Add like
Add dislike
Add to saved papers

Heterogeneity of paucigranulocytic asthma: A prospective cohort study with hierarchical cluster analysis.

BACKGROUND: Asthma, a heterogeneous disease, can be divided into four inflammatory phenotypes using induced sputum cell counts -eosinophilic asthma (EA), neutrophilic asthma (NA), mixed granulocytic asthma (MGA), and paucigranulocytic asthma (PGA). While research has focused on EA and NA, there is little known on PGA.

OBJECTIVE: To study the heterogeneity of PGA, and identify possible PGA clusters to guide clinical treatment.

METHODS: Patients with PGA were grouped by hierarchical cluster analysis, and enrolled into a prospective cohort study to validate the clusters, relative to future risk of asthma exacerbations in a real-world setting. Clusters were validated by tree analysis in a separate population. Finally, we explored PGA stability.

RESULTS: Cluster analysis of 145 patients with PGA identified three clusters: Cluster 1 (n = 110, 75.9%) was "mild PGA," Cluster 2 (n = 20, 13.8%) was "PGA with psychological dysfunction and rhinoconjunctivitis and other allergic diseases," and Cluster 3 (n = 15, 10.3%) was "smoking-associated PGA." Cluster 3 had significantly increased risk of severe exacerbation (RR = 6.43, P = 0.01), emergency visit (RR = 8.61, P = 0.03), and hospitalization (RR = 12.94, P < 0.01). Results of the cluster analysis were successfully validated in an independent PGA population classified using decision tree analysis. Although PGA can transform into or develop from other phenotypes, 70% were stable over time.

CONCLUSIONS: Among three identified PGA clusters, Cluster 3 had a higher risk of severe exacerbation. PGA heterogeneity indicates the requirement of novel targeted interventions.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app